Improving access to clinical trials
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to be part of one.
Expanding trial access – ICR report
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with cancer. But Covid-19 also offers clues to a recovery that can get new treatments to cancer patients more quickly.
News: Cancer trial recruitment drops by 60 per cent during pandemic
The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying drug development. Here, cancer experts set out their findings about the barriers to carrying out clinical trials in the UK and proposals for boosting participation.Latest ICR News
Men can be safely treated with two radiotherapy sessions for localised prostate cancer with no increase in side effects in comparison to five sessions
Men with localised prostate cancer could benefit from a shorter course of radiotherapy, after new research data shows that just two higher-dose treatments are as safe as a standard five-session regimen, with no increase in side effects.
Childhood leukaemia and germs: research reveals the critical importance of timing
New research has endorsed a long standing idea explaining why acute lymphoblastic leukaemia (ALL) – the most common cancer in children – appears abruptly in early life, often in otherwise healthy individuals, with no obvious environmental trigger.
-growing-in-single-files-along-collagen-fibres-(red)_renee-flaherty.jpg?sfvrsn=b3bf3bc8_3 "Invasive lobular breast cells (yellow) growing in single files along collagen fibres (red)_Renee Flaherty")
The ICR and Breast Cancer Now strengthen collaborative programme to tackle lobular breast cancer
The Institute of Cancer Research, London, and Breast Cancer Now are building on their long‑standing collaboration with a major initiative focused on improving treatment for lobular breast cancer.
Newly discovered role for cancer-linked protein exposes vulnerability in tumour cells
Scientists have uncovered a previously hidden role for a protein frequently mutated in cancer, showing that it helps maintain the stability of the genome at some of its most vulnerable sites.